Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Operating Expenses: 2023-2024

Historic Operating Expenses for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $168.9 million.

  • Zenas BioPharma's Operating Expenses rose 28.29% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.7 million, marking a year-over-year increase of 62.13%. This contributed to the annual value of $168.9 million for FY2024, which is 93.80% up from last year.
  • Per Zenas BioPharma's latest filing, its Operating Expenses stood at $168.9 million for FY2024, which was up 93.80% from $87.1 million recorded in FY2023.
  • Over the past 5 years, Zenas BioPharma's Operating Expenses peaked at $168.9 million during FY2024, and registered a low of $87.1 million during FY2023.
  • Its 2-year average for Operating Expenses is $128.0 million, with a median of $128.0 million in 2023.
  • Data for Zenas BioPharma's Operating Expenses shows a peak YoY spiked of 93.80% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Operating Expenses stood at $87.1 million in 2023, then skyrocketed by 93.80% to $168.9 million in 2024.